Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021


HomeSterling Partners:Sterling Partners and its Incubator ’87 Partner with Stella Center for Trauma Symptom Care

Sterling Partners and its Incubator ’87 Partner with Stella Center for Trauma Symptom Care

Sterling Chairman & Co-Founder Steven Taslitz and Team Are Working to Expand Access to Neurological Trauma Symptom Care

Sterling Partners and its investment incubator ‘87 announced today the formation of a new managed services organization (MSO), Stella MSO, LLC, which will provide services to Stella Center, a new model of care for individuals seeking treatment of neurological trauma-related symptoms.

Stella Center provides care to patients with a 20-minute outpatient medical procedure called a modified Stellate Ganglion Block (SGB) that targets the brain’s fight or flight response to help alleviate symptoms related to neurological trauma. These symptoms range from relationship and sleep problems to panic attacks and surges of irritability and afflict those from all walks of life, including military personnel, veterans and first responders. The procedure and Stella Center draw on the years of experience of highly regarded, board-certified anesthesiologist and Stella Center’s Chief Medical Officer Dr. Eugene Lipov. Dr. Lipov has administered the SGB procedure more than 1,000 times in patients with trauma-related symptoms.

The formation of the MSO and its first partnership with a physical center for care, located just outside of downtown Chicago, was led by Sterling Partners (“Sterling”) Chairman and Co-Founder Steven Taslitz. Taslitz was introduced to Dr. Lipov and licensed psychologist and veteran trauma specialist Dr. Shauna Springer in early 2019, and together they sought to create a patient-first center designed to improve the lives of those impacted by trauma. Furthermore, the partnership complemented Taslitz’s desire to build and scale businesses that benefit veteran communities, just as his team did through an investment in Black Rifle Coffee Company. Together Dr. Lipov, Dr. Springer, Taslitz, and ‘87 are building a platform that could expand nationally to increase access to this method of care, and in communities with large concentrations of military personnel.

“The Department of Veterans Affairs estimates that Post-Traumatic Stress Disorder will affect 7% to 8% of the population at some point in life,” explained Taslitz. “When we were approached by Dr. Lipov to assist him in expanding his model that seeks to meaningfully improve people’s lives, we couldn’t help but roll up our sleeves. Stella Center is an opportunity for us to draw on our years of experience in healthcare investing and our entrepreneurial roots. We’re excited to be on the forefront of addressing the challenge of effective and scalable trauma-related symptom care.”

Through the creation of Stella’s MSO, Sterling and ’87 provide Stella Center strategic guidance on finance, talent, branding, and marketing. Sterling has nearly 40 years of investment and business-building experience and a long-standing practice in multi-unit healthcare services. With Sterling’s addition of ‘87, which brings expertise in growth marketing and brand building, the partnership with Stella Center seemed particularly well-suited. Dr. Lipov controls the center itself and the services provided there, alongside CEO James R. Williams. Williams, like Sterling, is a proven healthcare leader, having previously expanded and led U.S. care networks for companies including DaVita, Vein Clinics of America, Accelitech, and ProCure.

Stella Center’s first physical location is now open at 2425 22nd St., Suite 101, Oak Brook, IL, 60523. It is administering treatment as appropriate while adhering to physical distancing requirements. Its call center is also open to consult with potential patients and outline treatment options through its telehealth platform. With Drs. Lipov and Springer’s direction, Stella Center is evaluating opening new brick and mortar locations, focused in active duty and veteran-heavy geographies, and hiring top-tier clinical staff.

“This is a promising time in the advancement of care for the biological and neurological effects of trauma,” added Lipov. “I’m thrilled to be working with Sterling Partners and ’87, who have extensive experience in building great healthcare organizations and positive patient experiences. Our goal is to provide hope and healing to patients struggling with trauma-related symptoms.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy